Skip to content

Clinical trials

Phase 2 Kidney Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Diseases Phase: Phase 2 Clear all

111 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20042
20054
20067
20074
20085
20093
201010
20115
20124
20143
20156
20165
20177
20184
20197
20204
20214
20224
20236
20241
20257
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed73
Terminated14
Recruiting10
Not yet recruiting4
Unknown status4
Active, not recruiting3
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)4
Allena Pharmaceuticals3
Erling Bjerregaard Pedersen3
Novartis Pharmaceuticals3
Otsuka Pharmaceutical Development & Commercialization, Inc.3
Regional Hospital Holstebro3
University of Washington3
Akebia Therapeutics2
AstraZeneca2
Catalysis SL2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Diseases111
Renal Insufficiency, Chronic20
Diabetes Mellitus15
Urologic Diseases14
Renal Insufficiency12
Glomerulonephritis11
Diabetic Nephropathies10
Glomerulonephritis, IGA10
Hypertension9
Proteinuria9

Trials

Showing 76 to 100 of 111. Each trial links to its page on Pharma Observatory.

11 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.